One prominent variant, AR-V7, enhances the expression of DNA repair genes and confers radioresistance in various PCa cell lines, indicating that targeting AR-Vs could not only address the resistance to ARSIs, but also augment RT and potentially other therapies targeting the DDR [86,87]. This evidence concerns the gene AR and posterior cortical atrophy.